Artificial Intelligence in Drug Discovery Market
Artificial Intelligence in Drug Discovery Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Artificial Intelligence in Drug Discovery Market Size and Growth
The Artificial Intelligence in Drug Discovery market is rapidly growing, driven by advancements in computational technology and the need for faster drug development. The market is projected to reach approximately $3.9 billion by 2026, reflecting a CAGR of around 40%. Increasing investments and collaborations are enhancing innovation in pharmaceutical research.
Companies Covered
(Covid 19 Impact Covered)
◍ IBM
◍ Microsoft
◍ NVIDIA Corporation
◍ Atomwise, Inc.
◍ Deep Genomics
◍ Cloud Pharmaceuticals
◍ Insilico Medicine
◍ BenevolentAI
◍ Exscientia
◍ Cyclica
◍ BIOAGE
◍ Numerate
◍ NuMedii
◍ Envisagenics
◍ twoXAR
◍ OWKIN, Inc.
The AI in drug discovery market features major players like IBM, Microsoft, Google, and NVIDIA, leveraging AI to enhance compound screening, predictive modeling, and clinical trial optimization. Companies like Atomwise and BenevolentAI focus on molecular simulations. Sales figures: IBM's Watson Health reported $1 billion; BenevolentAI secured $227 million in funding.
◍ XtalPi
Request Sample Report
Market Segmentation
By Application
◍ Pharmaceutical and Biotechnology Companies
◍ Contract Research Organizations
◍ Research Centers and Academic & Government Institutes
By Product
Software
Services
Request Sample Report
$ 21.50 Billion
Request Sample Report
